drugset

drugset / Trial / NCT00074646

Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas

NCT00074646 ↗

Phase 1 Completed 36 enrolled Celgene Corporation

RandomizedOpen-labelTreatment

Summary

Phase I trial of CC-8490 for the treatment of subjects with recurrent/refractory high-grade gliomas

Timeline

Start: 2003-12
Primary completion: —
Completion: 2005-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CC-8490	Unknown	—	—

Indications